Libtayo Sets a New Standard for CSCC Treatment at ESMO 2023 Melanoma and Skin 2 Mins Read6 By. Neil Gross, MDDate. October 26, 2023 In a discussion detailing the primary outcomes of the Phase 2 trial for…
